These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30700566)

  • 1. Prognostic significance of residual disease in advanced stage malignant ovarian germ cell tumors.
    Nasioudis D; Chapman-Davis E; Frey MK; Caputo TA; Witkin SS; Holcomb K
    Int J Gynecol Cancer; 2019 Mar; 29(3):554-559. PubMed ID: 30700566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fertility-preserving surgery for advanced stage ovarian germ cell tumors.
    Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb K
    Gynecol Oncol; 2017 Dec; 147(3):493-496. PubMed ID: 29021083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoreductive surgery in advanced stage malignant ovarian germ cell tumors.
    Karalok A; Comert GK; Kilic C; Turkmen O; Kilic F; Basaran D; Boyraz G; Tekin ÖM; Turan T
    J Gynecol Obstet Hum Reprod; 2019 Sep; 48(7):461-466. PubMed ID: 31228608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
    Yang ZJ; Liu ZC; Wei RJ; Li L
    Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the surgical management of malignant ovarian germcell tumors.
    Nasioudis D; Mastroyannis SA; Latif NA; Ko EM
    Gynecol Oncol; 2020 Apr; 157(1):89-93. PubMed ID: 32008791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of hospital surgical volume on complete gross resection (CGR) rates following primary debulking surgery for advanced stage epithelial ovarian carcinoma.
    Nasioudis D; Kahn R; Chapman-Davis E; Frey MK; Caputo TA; Witkin SS; Holcomb K
    Gynecol Oncol; 2019 Aug; 154(2):401-404. PubMed ID: 31160074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors.
    Turkmen O; Karalok A; Basaran D; Kimyon GC; Tasci T; Ureyen I; Tulunay G; Turan T
    J Adolesc Young Adult Oncol; 2017 Jun; 6(2):270-276. PubMed ID: 28085535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Strategy for the Treatment of Ovarian Germ Cell Tumors: Role of Extensive Surgery.
    Li J; Wu X
    Curr Treat Options Oncol; 2016 Aug; 17(8):44. PubMed ID: 27357180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
    Li J; Yang W; Wu X
    Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
    Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
    Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgery.
    Nasioudis D; Wang X; Dhillon G; Latif N; Ko EM; Giuntoli RL; Gershenson D; Fader A; Carey M; Simpkins F
    Int J Gynecol Cancer; 2023 Dec; 33(12):1906-1912. PubMed ID: 37879909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Impact of Lymphadenectomy in Different Stages of Malignant Germ Cell Tumor of the Ovary Based on Propensity Score Matching.
    Chen Y; Ning Y; Zhang Q; Xie Y
    Comb Chem High Throughput Screen; 2018; 21(9):652-661. PubMed ID: 30569854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascites volume at the time of primary debulking and overall survival of patients with advanced epithelial ovarian cancer.
    Nasioudis D; Byrne M; Ko EM; Haggerty AF; Cory L; Giuntoli Ii RL; Kim SH; Latif NA
    Int J Gynecol Cancer; 2021 Dec; 31(12):1579-1583. PubMed ID: 34702746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical resection and outcome of malignant ovarian germ cell tumors in children-a national multicentric study compared to international results.
    Elgendy A; Mostafa M; Salem MA; Ali A; Khairi A; Shehata S
    Pediatr Surg Int; 2020 Sep; 36(9):1067-1075. PubMed ID: 32681191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
    Yang ZJ; Wei RJ; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer.
    Chang SJ; Bristow RE; Ryu HS
    Ann Surg Oncol; 2012 Dec; 19(13):4059-67. PubMed ID: 22766983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germ cell tumors of the ovary.
    Pectasides D; Pectasides E; Kassanos D
    Cancer Treat Rev; 2008 Aug; 34(5):427-41. PubMed ID: 18378402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between residual disease and survival in epithelial ovarian cancer by histologic type.
    Melamed A; Manning-Geist B; Bregar AJ; Diver EJ; Goodman A; Del Carmen MG; Schorge JO; Rauh-Hain JA
    Gynecol Oncol; 2017 Nov; 147(2):250-256. PubMed ID: 28822556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant germ cell tumors of the ovary: a review of 41 cases and risk factors for recurrence.
    Topuz S; Iyibozkurt AC; Akhan SE; Keskin N; Yavuz E; Salihoglu Y; Bengisu E; Berkman S
    Eur J Gynaecol Oncol; 2008; 29(6):635-7. PubMed ID: 19115694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and rationale of a novel approach in advanced ovarian cancer surgery: Bat- shaped en-bloc total peritonectomy and total hysterectomy salpingo-oophorectomy with or without rectosigmoid resection (Sarta-Bat approach).
    Khatib G; Seyfettinoglu S; Guzel AB; Gulec UK; Unlugenc H; Vardar MA
    Gynecol Oncol; 2021 Apr; 161(1):97-103. PubMed ID: 33234261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.